NCT03180957 2024-06-28
RIDD
University of Oxford
Phase 2 Completed
Clinical Trials
13 trialsNCT02725528 2023-07-18
EXTEND
McMaster University
Phase 3 Completed
NCT00528606 2017-12-02
CORD-I
Endo Pharmaceuticals
Phase 3 Completed
NCT00528931 2017-10-05
A Pharmacokinetic Study of AA4500 (XIAFLEXâ„¢, Proposed Name) in Subjects With Dupuytren's Contracture
Endo Pharmaceuticals
Phase 1 Completed
NCT01407068 2017-10-05
Administration of Two Injections for Multiple Dupuytren's Contractures
Endo Pharmaceuticals
Phase 3 Completed
NCT01498640 2017-10-05
Retreatment of Recurrent Dupuytren's Contractures
Endo Pharmaceuticals
Phase 4 Completed
NCT02193828 2017-10-05
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Endo Pharmaceuticals
Phase 2 Completed
NCT01450397 2017-04-17
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
Hospital for Special Surgery, New York
Phase 4 Completed
NCT01588353 2017-03-21
CORD-J
Asahi Kasei Pharma Corporation
Phase 3 Completed
NCT01265420 2015-04-30
Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb
Indiana Hand to Shoulder Center
Phase 4 Completed
NCT01226121 2014-06-16
Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture
Indiana Hand to Shoulder Center
Phase 4 Terminated
NCT01229436 2014-03-17
POINT X
Pfizer
Phase 3 Completed
NCT00260429 2010-12-09
Collagenase in the Treatment of Dupuytrens Disease
Stony Brook University
Phase 3 Completed